• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA测序分析确定了与三阴性乳腺癌预后相关的激素相关基因。

RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer.

作者信息

Chen Fei, Li Yuancheng, Qin Na, Wang Fengliang, Du Jiangbo, Wang Cheng, Du Fangzhi, Jiang Tao, Jiang Yue, Dai Juncheng, Hu Zhibin, Lu Cheng, Shen Hongbing

机构信息

Department of Breast Surgery, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, Jiangsu 210004, China;Department of Epidemiology, Center for Global Health, School of Public Health.

Department of Epidemiology, Center for Global Health, School of Public Health.

出版信息

J Biomed Res. 2020 Jan 29;34(2):129-138. doi: 10.7555/JBR.34.20190111.

DOI:10.7555/JBR.34.20190111
PMID:32305967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7183303/
Abstract

Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer that currently lacks effective biomarkers and therapeutic targets required to investigate the diagnosis and treatment of TNBC. Here we performed a comprehensive differential analysis of 165 TNBC samples by integrating RNA-seq data of breast tumor tissues and adjacent normal tissues from both our cohort and The Cancer Genome Atlas (TCGA). Pathway enrichment analysis was conducted to evaluate the biological function of TNBC-specific expressed genes. Further multivariate Cox proportional hazard regression was performed to evaluate the effect of these genes on TNBC prognosis. In this report, we identified a total of 148 TNBC-specific expressed genes that were primarily enriched in mammary gland morphogenesis and hormone levels related pathways, suggesting that mammary gland morphogenesis might play a unique role in TNBC patients differing from other breast cancer types. Further survival analysis revealed that nine genes ( , , , , , , , , and ) were significantly associated with the prognosis of TNBC patients, while three of them ( , , and ) were involved in the hormone-related pathways. These findings indicated the vital role of the hormone-related genes in TNBC tumorigenesis and may provide some independent prognostic markers as well as novel therapeutic targets for TNBC.

摘要

三阴性乳腺癌(TNBC)是一种侵袭性乳腺癌亚型,目前缺乏用于研究TNBC诊断和治疗所需的有效生物标志物和治疗靶点。在此,我们通过整合来自我们的队列以及癌症基因组图谱(TCGA)的乳腺肿瘤组织和相邻正常组织的RNA测序数据,对165例TNBC样本进行了全面的差异分析。进行通路富集分析以评估TNBC特异性表达基因的生物学功能。进一步进行多变量Cox比例风险回归以评估这些基因对TNBC预后的影响。在本报告中,我们共鉴定出148个TNBC特异性表达基因,这些基因主要富集于乳腺形态发生和激素水平相关通路,这表明乳腺形态发生可能在TNBC患者中发挥与其他乳腺癌类型不同的独特作用。进一步的生存分析显示,九个基因( , , , , , , , ,和 )与TNBC患者的预后显著相关,其中三个基因( , ,和 )参与激素相关通路。这些发现表明激素相关基因在TNBC肿瘤发生中起着至关重要的作用,并可能为TNBC提供一些独立的预后标志物以及新的治疗靶点。

相似文献

1
RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer.RNA测序分析确定了与三阴性乳腺癌预后相关的激素相关基因。
J Biomed Res. 2020 Jan 29;34(2):129-138. doi: 10.7555/JBR.34.20190111.
2
Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer.预测三阴性乳腺癌发病机制和预后的潜在关键基因及通路的鉴定
Cancer Cell Int. 2019 Jun 28;19:172. doi: 10.1186/s12935-019-0884-0. eCollection 2019.
3
Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.三阴性乳腺癌中lncRNAs/mRNAs和miRNAs差异表达谱及相关ceRNA网络的综合分析
Cell Physiol Biochem. 2018;50(2):473-488. doi: 10.1159/000494162. Epub 2018 Oct 11.
4
Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing.通过异常可变剪接的综合表征对三阴性乳腺癌预后的新见解
Front Genet. 2020 Jun 11;11:534. doi: 10.3389/fgene.2020.00534. eCollection 2020.
5
Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.全面分析新型三长非编码 RNA 标志物作为人类三阴性乳腺癌的诊断和预后生物标志物。
J Cell Biochem. 2019 Mar;120(3):3185-3196. doi: 10.1002/jcb.27584. Epub 2018 Sep 11.
6
Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis.基于综合生物信息学分析鉴定与三阴性乳腺癌发病机制、转移及预后相关的潜在关键基因
Front Oncol. 2020 Jun 12;10:856. doi: 10.3389/fonc.2020.00856. eCollection 2020.
7
Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer.基于组学整合的通路分析揭示 CYP 加单氧酶相关网络作为转移性三阴性乳腺癌的治疗靶点。
J Exp Clin Cancer Res. 2019 May 9;38(1):187. doi: 10.1186/s13046-019-1187-y.
8
Prognostic Alternative mRNA Splicing Signature and a Novel Biomarker in Triple-Negative Breast Cancer.三阴性乳腺癌中具有预后价值的替代 mRNA 剪接特征和新型生物标志物。
DNA Cell Biol. 2020 Jun;39(6):1051-1063. doi: 10.1089/dna.2020.5460. Epub 2020 Apr 30.
9
SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.SPAG5 上调通过与三阴性乳腺癌中 c-MYC 结合蛋白相互作用促进 c-MYC 转录活性。
J Hematol Oncol. 2019 Feb 8;12(1):14. doi: 10.1186/s13045-019-0700-2.
10
Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer.G蛋白信号调节因子20与三阴性乳腺癌的临床病理特征及预后相关。
Biochem Biophys Res Commun. 2017 Apr 8;485(3):693-697. doi: 10.1016/j.bbrc.2017.02.106. Epub 2017 Feb 22.

引用本文的文献

1
Identification and experimental validation of prognostic genes related to cytochrome c in breast cancer.乳腺癌中与细胞色素c相关的预后基因的鉴定及实验验证
Front Genet. 2025 Aug 11;16:1627134. doi: 10.3389/fgene.2025.1627134. eCollection 2025.
2
Perturbing local steroidogenesis to improve breast cancer immunity.扰动局部类固醇生成以改善乳腺癌免疫。
Nat Commun. 2025 Apr 26;16(1):3945. doi: 10.1038/s41467-025-59356-3.
3
HDAC10 inhibits non-small-cell lung cancer cell ferroptosis through the microRNA-223-5p-SLC7A11 axis.组蛋白去乙酰化酶10通过微小RNA-223-5p-SLC7A11轴抑制非小细胞肺癌细胞铁死亡。
Toxicol Res (Camb). 2024 Oct 13;13(5):tfae164. doi: 10.1093/toxres/tfae164. eCollection 2024 Oct.
4
Characterizing the Tumor Microenvironment and Its Prognostic Impact in Breast Cancer.描绘乳腺癌的肿瘤微环境及其预后影响。
Cells. 2024 Sep 10;13(18):1518. doi: 10.3390/cells13181518.
5
The analysis of transcriptomic signature of TNBC-searching for the potential RNA-based predictive biomarkers to determine the chemotherapy sensitivity.三阴性乳腺癌转录组特征分析——寻找潜在的基于RNA的预测生物标志物以确定化疗敏感性。
J Appl Genet. 2025 Feb;66(1):171-182. doi: 10.1007/s13353-024-00876-x. Epub 2024 May 9.
6
Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors.对趋化因子样因子(CKLF)样膜域包含家族(CMTM)的研究见解:它们在各种肿瘤中的作用。
PeerJ. 2024 Jan 10;12:e16757. doi: 10.7717/peerj.16757. eCollection 2024.
7
The RNA m5C modification in R-loops as an off switch of Alt-NHEJ.R 环中 RNA m5C 修饰作为替代 NHEJ 的关闭开关。
Nat Commun. 2023 Sep 30;14(1):6114. doi: 10.1038/s41467-023-41790-w.
8
Current Opinions on the Relationship Between CMTM Family and Hepatocellular Carcinoma.关于CMTM家族与肝细胞癌关系的当前观点
J Hepatocell Carcinoma. 2023 Aug 25;10:1411-1422. doi: 10.2147/JHC.S417202. eCollection 2023.
9
Expression profiling of luminal B breast tumor in Indian women.印度女性管腔B型乳腺肿瘤的表达谱分析。
J Cancer Res Clin Oncol. 2023 Nov;149(15):13645-13664. doi: 10.1007/s00432-023-05195-y. Epub 2023 Jul 30.
10
A Focus on the Synergy of Radiomics and RNA Sequencing in Breast Cancer.聚焦于放射组学和 RNA 测序在乳腺癌中的协同作用。
Int J Mol Sci. 2023 Apr 13;24(8):7214. doi: 10.3390/ijms24087214.

本文引用的文献

1
The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology.雄激素受体在乳腺癌中的不同功能;类固醇介质与肿瘤内分泌学分析
Front Endocrinol (Lausanne). 2018 Oct 26;9:594. doi: 10.3389/fendo.2018.00594. eCollection 2018.
2
AFF3 upregulation mediates tamoxifen resistance in breast cancers.AFF3 上调介导了乳腺癌对他莫昔芬的耐药性。
J Exp Clin Cancer Res. 2018 Oct 16;37(1):254. doi: 10.1186/s13046-018-0928-7.
3
CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling.CMTM5表达下调,并通过调节PI3K-AKT信号通路抑制肝细胞癌的肿瘤生长。
Cancer Cell Int. 2017 Nov 29;17:113. doi: 10.1186/s12935-017-0485-8. eCollection 2017.
4
Immune checkpoint inhibitors in cancer therapy.癌症治疗中的免疫检查点抑制剂。
J Biomed Res. 2018 Sep 29;32(5):317-326. doi: 10.7555/JBR.31.20160168.
5
Steroid hormone receptors as prognostic markers in breast cancer.类固醇激素受体作为乳腺癌的预后标志物
Am J Cancer Res. 2017 Aug 1;7(8):1617-1636. eCollection 2017.
6
FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness.FSIP1 通过直接结合 HER2 来调节乳腺癌的生长和侵袭。
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):7683-7688. doi: 10.1073/pnas.1621486114. Epub 2017 Jul 3.
7
Clinical utility of gene-expression signatures in early stage breast cancer.早期乳腺癌中基因表达谱的临床实用性。
Nat Rev Clin Oncol. 2017 Oct;14(10):595-610. doi: 10.1038/nrclinonc.2017.74. Epub 2017 May 31.
8
Abnormal expression of and in breast cancer.乳腺癌中[具体基因名称未给出]和[具体基因名称未给出]的异常表达。
F1000Res. 2017 Jan 5;6:10. doi: 10.12688/f1000research.10481.1. eCollection 2017.
9
Molecular alterations in triple-negative breast cancer-the road to new treatment strategies.三阴性乳腺癌的分子改变——新治疗策略之路。
Lancet. 2017 Jun 17;389(10087):2430-2442. doi: 10.1016/S0140-6736(16)32454-0. Epub 2016 Dec 7.
10
The presence and impact of estrogen metabolism on the biology of triple-negative breast cancer.雌激素代谢在三阴性乳腺癌生物学中的存在及其影响。
Breast Cancer Res Treat. 2017 Jan;161(2):213-227. doi: 10.1007/s10549-016-4050-2. Epub 2016 Nov 15.